Εμφανίζονται 1 - 20 Αποτελέσματα από 49 για την αναζήτηση '"резекция поджелудочной железы"', χρόνος αναζήτησης: 0,82δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Πηγή: Siberian journal of oncology; Том 23, № 5 (2024); 126-132 ; Сибирский онкологический журнал; Том 23, № 5 (2024); 126-132 ; 2312-3168 ; 1814-4861

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/3276/1277; He J., Ahuja N., Makary M.A., Cameron J.L., Eckhauser F.E., Choti M.A., Hruban R.H., Pawlik T.M., Wolfgang C.L. 2564 resected periam pullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014; 16(1): 83–90. doi:10.1111/hpb.12078.; Louvet C., Philip P.A. Accomplishments in 2007 in the treatment of metastatic pancreatic cancer. Gastrointest Cancer Res. 2008; 2(3s): 37–41.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7–30. doi:10.3322/caac.21590.; Mayo S.C., de Jong M.C., Pulitano C., Clary B.M., Reddy S.K., Gamblin T.C., Celinksi S.A., Kooby D.A., Staley C.A., Stokes J.B., Chu C.K., Ferrero A., Schulick R.D., Choti M.A., Mentha G., Strub J., Bauer T.W., Adams R.B., Aldrighetti L., Capussotti L., Pawlik T.M. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010; 17(12): 3129–36. doi:10.1245/s10434-010-1154-5.; Ejaz A., Reames B.N., Maithel S., Poultsides G.A., Bauer T.W., Fields R.C., Weiss M.J., Marques H.P., Aldrighetti L., Pawlik T.M. Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis. HPB (Oxford). 2018; 20(3): 277–84. doi:10.1016/j.hpb.2017.08.039.; Conroy T., Desseigne F., Ychou M., Bouché O., Guimbaud R., Bécouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardière C., Bennouna J., Bachet J.B., KhemissaAkouz F., Péré-Vergé D., Delbaldo C., Assenat E., Chauffert B., Michel P., Montoto-Grillot C., Ducreux M.; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 364(19): 1817–25. doi:10.1056/NEJMoa1011923.; Von Hoff D.D., Ervin T., Arena F.P., Chiorean E.G., Infante J., Moore M., Seay T., Tjulandin S.A., Ma W.W., Saleh M.N., Harris M., Reni M., Dowden S., Laheru D., Bahary N., Ramanathan R.K., Tabernero J., Hidalgo M., Goldstein D., van Cutsem E., Wei X., Iglesias J., Renschler M.F. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013; 369(18): 1691–703. doi:10.1056/NEJMoa1304369.; Crippa S., Bittoni A., Sebastiani E., Partelli S., Zanon S., Lanese A., Andrikou K., Muffatti F., Balzano G., Reni M., Cascinu S., Falconi M. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Eur J Surg Oncol. 2016; 42(10): 1533–9. doi:10.1016/j.ejso.2016.06.398.; Tachezy M., Gebauer F., Janot M., Uhl W., Zerbi A., Montorsi M., Perinel J., Adham M., Dervenis C., Agalianos C., Malleo G., Maggino L., Stein A., Izbicki J.R., Bockhorn M. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery. 2016; 160(1): 136–44. doi:10.1016/j.surg.2016.02.019.; Frigerio I., Regi P., Giardino A., Scopelliti F., Girelli R., Bassi C., Gobbo S., Martini P.T., Capelli P., D’Onofrio M., Malleo G., Maggino L., Viviani E., Butturini G. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Ann Surg Oncol. 2017; 24(8): 2397–403. doi:10.1245/s10434-017-5885-4.; Hellman S., Weichselbaum R.R. Oligometastases. J Clin Oncol. 1995; 13(1): 8–10. doi:10.1200/JCO.1995.13.1.8.; Hackert T., Niesen W., Hinz U., Tjaden C., Strobel O., Ulrich A., Michalski C.W., Büchler M.W. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol. 2017; 43(2): 358–63. doi:10.1016/j.ejso.2016.10.023.; Wright G.P., Poruk K.E., Zenati M.S., Steve J., Bahary N., Hogg M.E., Zuriekat A.H., Wolfgang C.L., Zeh H.J. 3rd, Weiss M.J. Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional Analysis. J Gastrointest Surg. 2016; 20(11): 1830–5. doi:10.1007/s11605-016-3256-2.; Klein F., Puhl G., Guckelberger O., Pelzer U., Pullankavumkal J.R., Guel S., Neuhaus P., Bahra M. The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol Res Pract. 2012. doi:10.1155/2012/939350.; Shi H., Li J., Fu D. Process of hepatic metastasis from pancreatic cancer: biology with clinical signifcance. J Cancer Res Clin Oncol. 2016; 142(6): 1137–61. doi:10.1007/s00432-015-2024-0.; Kajioka H., Kagawa S., Ito A., Yoshimoto M., Sakamoto S., Kikuchi S., Kuroda S., Yoshida R., Umeda Y., Noma K., Tazawa H., Fujiwara T. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Lett. 2021; 497: 1–13. doi:10.1016/j.canlet.2020.10.015.; Liang C., Qi Z., Ge H., Liang C., Zhang Y., Wang Z., Li R., Guo J. Long non-coding RNA PCAT-1 in human cancers: A meta-analysis. Clin Chim Acta. 2018; 480: 47–55. doi:10.1016/j.cca.2018.01.043.; Buscail L., Bournet B., Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020; 17(3): 153–68. doi:10.1038/s41575-019-0245-4.; Huo Y., Zhou Y., Zheng J., Jin G., Tao L., Yao H., Zhang J., Sun Y., Liu Y., Hu L.P. GJB3 promotes pancreatic cancer liver metastasis by enhancing the polarization and survival of neutrophil. Front Immunol. 2022; 13. doi:10.3389/fmmu.2022.983116.; Hermann C.D., Schoeps B., Eckfeld C., Munkhbaatar E., Kniep L., Prokopchuk O., Wirges N., Steiger K., Häußler D., Knolle P., Poulton E., Khokha R., Grünwald B.T., Demir I.E., Krüger A. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J Exp Med. 2021; 218(11). doi:10.1084/jem.20210911.; Moro L., Pagano M. Epigenetic suppression of FBXL7 promotes metastasis. Mol Cell Oncol. 2020; 7(6). doi:10.1080/23723556.2020.1833698.; Goulart M.R., Watt J., Siddiqui I., Lawlor R.T., Imrali A., Hughes C., Saad A., ChinAleong J., Hurt C., Cox C., Salvia R., Mantovani A., Crnogorac-Jurcevic T., Mukherjee S., Scarpa A., Allavena P., Kocher H.M. Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2021; 5(1): 61. doi:10.1038/s41698-021-00192-1.; Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., Reichert M., Beatty G.L., Rustgi A.K., Vonderheide R.H., Leach S.D., Stanger B.Z. EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1–2): 349–61. doi:10.1016/j.cell.2011.11.025.; Tuveson D.A., Neoptolemos J.P. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell. 2012; 148(1–2): 21–3. doi:10.1016/j.cell.2011.12.021.; Haeno H., Gonen M., Davis M.B., Herman J.M., IacobuzioDonahue C.A., Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012; 148(1–2): 362–75. doi:10.1016/j.cell.2011.11.060.; Addeo P., Oussoultzoglou E., Fuchshuber P., Rosso E., Nobili C., Langella S., Jaeck D., Bachellier P. Safety and outcome of combined liver and pancreatic resections. Br J Surg. 2014; 101(6): 693–700. doi:10.1002/bjs.9443.; Kim Y., Kim S.C., Song K.B., Kim J., Kang D.R., Lee J.H., Park K.M., Lee Y.J. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma. HPB (Oxford). 2016; 18(4): 325–31. doi:10.1016/j.hpb.2015.10.014.; Gebauer F., Damanakis A.I., Popp F., Quaas A., Kütting F., Lutz K., Held S., Deuß B., Göser T., Waldschmidt D., Bruns C. Study protocol of an open-label, single arm phase II trial investigating the efcacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fuorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC). BMC Cancer. 2021; 21(1): 1239. doi:10.1186/s12885-021-08966-3.; Yamanaka M., Hayashi M., Yamada S., Sonohara F., Takami H., Inokawa Y., Shimizu D., Hattori N., Kanda M., Tanaka C., Nakayama G., Koike M., Kodera Y. A Possible Defnition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes. Anticancer Res. 2021; 41(8): 3933–40. doi:10.21873/anticanres.15189.; Satoi S., Yamamoto T., Hashimoto D., Yamaki S., Matsui Y., Ikeura T., Boku S., Shibata N., Tsybulskyi D., Sekimoto M. Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study. J Gastrointest Oncol. 2023; 14(6): 2587–99. doi:10.21037/jgo-23-655.; Ushida Y., Inoue Y., Oba A., Mie T., Ito H., Ono Y., Sato T., Ozaka M., Sasaki T., Saiura A., Sasahira N., Takahashi Y. Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modifed FOLFIRINOX or Gemcitabine Plus Nabpaclitaxel: A Single-Center Retrospective Study. Ann Surg Oncol. 2022; 29(8): 5038–50. doi:10.1245/s10434-022-11503-6.; Hamad A., Underhill J., Ansari A., Thayaparan V., Cloyd J.M., Li Y., Pawlik T.M., Tsung A., Abushahin L., Ejaz A. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database. Surgery. 2022; 171(6): 1464–70. doi:10.1016/j.surg.2021.12.029.; Tanaka M., Heckler M., Mihaljevic A.L., Sun H., Klaiber U., Heger U., Büchler M.W., Hackert T. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. Eur J Surg Oncol. 2019; 45(8): 1453–9. doi:10.1016/j.ejso.2019.03.039.; De Simoni O., Scarpa M., Tonello M., Pilati P., Tolin F., Spolverato Y., Gruppo M. Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and MetaAnalysis. Cancers (Basel). 2020; 12(11): 3402. doi:10.3390/cancers12113402.; Schwarz C., Fitschek F., Primavesi F., Stättner S., Margonis G.A., Weiss M.A., Stavrou G.A., Oldhafer K.J., Kornprat P., Wundsam H., Fischer I., Längle F., Függer R., Hauer A., Klug R., Kieler M., Prager G., Schindl M., Stremitzer S., Bodingbauer M., Sahora K., Kaczirek K. Metachronous hepatic resection for liver only pancreatic metastases. Surg Oncol. 2020; 35: 169–73. doi:10.1016/j.suronc.2020.08.005.; Zhou W., Wang D., Lou W. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Cancer Control. 2020; 27(1): 1–7. doi:10.1177/1073274820976593.; Mitsuka Y., Yamazaki S., Yoshida N., Yan M., Higaki T., Takayama T. Time interval-based indication for liver resection of metastasis from pancreatic cancer. World J Surg Oncol. 2020; 18(1): 294. doi:10.1186/s12957-020-02058-5.; https://www.siboncoj.ru/jour/article/view/3276

  2. 2
  3. 3
    Academic Journal

    Πηγή: Surgery and Oncology; Том 11, № 3-4 (2021); 18-22 ; Хирургия и онкология; Том 11, № 3-4 (2021); 18-22 ; 2949-5857

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/519/372; Ehrhardt O. Ueber Resektionen am Pancreas. Dtsch med Wochenschr 1908;34:595–7.; Beger H.G., Poch B., Mayer B., Siech M. New onset of diabetes and pancreatic exocrine insufficiency after pancreaticoduodenectomy for benign and malignant tumors: a systematic review and metaanalysis of long-term results. Ann Surg 2018;267(2):259–70. DOI:10.1097/SLA.0000000000002422.; Regmi P., Yang Q., Hu H.-J. et al. Overall postoperative morbidity and pancreatic fistula are relatively higher after central pancreatectomy than distal pancreatic resection: a systematic review and metaanalysis. Biomed Res Int 2020;2020:7038907. DOI:10.1155/2020/7038907.; Clavien P.A., Barkun J., de Oliveiraet M. et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250(2):187–96. DOI:10.1097/SLA.0b013e3181b13ca2.; Bassi C., Marchegiani G., Derveniset Ch. et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161(3):584– 91. DOI:10.1016/j.surg.2016.11.014.; Kimura W., Inoue T., Futakawa N. et al. Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein. Surgery 1996;120(5):885–90. DOI:10.1016/s0039-6060(96)80099-7.; Xiao W., Zhu J., Peng L. et al. The role of central pancreatectomy in pancreatic surgery: a systematic review and metaanalysis. HPB (Oxford) 2018;20(10):896– 904. DOI:10.1016/j.hpb.2018.05.001.; Dragomir M.P., Sabo A., Petrescuet G. et al. Central pancreatectomy: a comprehensive, up-to-date meta-analysis. Langenbeck’s Arch Surg 2019;404(8): 945–58. DOI:10.1007/s00423-019-01829-3.

  4. 4
    Academic Journal

    Πηγή: Surgery and Oncology; Том 11, № 3-4 (2021); 40-45 ; Хирургия и онкология; Том 11, № 3-4 (2021); 40-45 ; 2949-5857

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/523/376; Weiss S.W., Goldblum J.R. Leiomyosarcoma. In: Enzinger and Weiss’s Soft Tissue Tumors. 4th edn. Mosby, St. Louis, 2001.; Rajiah P., Sinha R., Cuevas C. Imaging of uncommon retroperitoneal masses. RadioGraphics 2011;31(4):949–76. DOI:10.1148/rg.314095132.; Baylor S.M., Berg J.W. Cross classification and survival characteristics of 5000 cases of cancer of the pancreas. J Surg Oncol 1973;5:335–58. DOI:10.1002/jso.2930050410.; Ross C. Leiomyosarcoma of the pancreas. Brit J Surg 1951;39(153):53–6. DOI:10.1002/bjs.18003915311.; Aleshawi A., Allouh, M., Heis F. et al. Primary leiomyosarcoma of the pancreas: a comprehensive analytical review. J Gastrointest Cancer 2019;51(2):433–38. DOI:10.1007/s12029-019-00282-1.; Riddle N., Quigley B., Browarsky I., Bui M. Leiomyosarcoma arising in the pancreatic duct: a case report and review of the current literature. Case Rep Med 2010:1–4. DOI:10.1155/2010/252364.; Patrono D., Molinaro L., Mazza E. et al. Splenic vein leiomyosarcoma: case report and review of the literature. JOP 2014;15(5):512–4. DOI:10.6092/1590-8577/2803.; Лагкуева И.Д., Ребрикова В.А., Егорова Е.В. и др. Компьютерно-томографическая семиотика лейомиосаркомы забрюшинной локализации, исходящей из мышечной стенки селезеночной вены (клиническое наблюдение). Сибирский онкологический журнал 2019;17(6):123–7. [Lagkueva I., Rebrikova V., Egorova E. et al. Computer tomographic semiotics of retroperitoneal leiomyosarcoma arising from the muscular wall of the splenic vein: a case report. Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology 2019;17(6):123–7. (In Russ.)]. DOI:10.21294/1814-4861-2018-17-6-123-127.; Akhaladze G., Grebenkin E., Goncharov S. et al. Leiomyosarcoma of the splenic vein. Khirurgiya. Zhurnal im. N.I. Pirogova 2019;(10):82. DOI:10.17116/hirurgia201910182.; Nordback I., Mattila J., Tarkka M. Resectable leiomyosarcoma of inferior vena cava presenting as carcinoma of the pancreas. Case report. Acta Chir Scand 1990;156:577–80.; Xu J., Zhang T., Wang T. et al. Clinical characteristics and prognosis of primary leiomyosarcoma of the pancreas: a systematic review. World J Surg Oncol 2013;11(1):290. DOI:10.1186/1477-7819-11-290.; Russ P.D. Leiomyosarcoma of the pancreatic bed detected on CT scans. AJR Am J Roentgenol 1993;161(1):210. DOI:10.2214/ajr.161.1.8517309.; Diz Rodriguez M.R., Virseda Chamorro M., Ramirez Garcia J.R. et al. Scrotal leiomyosarcoma with bone metastasis. Acta Urol Esp 2006;30(6):638–40. DOI:10.1016/s0210-4806(06)73507-0.; Tilkorn D.J., Lehnhardt M., Hauser J. et al. Intravascular leiomyosarcoma of the brachiocephalic region – report of an unusual tumour localisation: case report and review of the literature. World J Surg Oncol 2008;6:113. DOI:10.1186/1477-7819-6-113.; Miura F., Takada T., Amano H. et al. Diagnosis of pancreatic cancer. HPB (Oxford) 2006;8(5):337–42. 16. O’Sullivan P.J., Harris A.C., Munk P.L. Radiological imaging features of nonuterine leiomyosarcoma. Br J Radiol 2008;81(961):73–81. DOI:10.1259/bjr/18595145.; Burke A.P., Virmani R., Sarcomas of the great vessels. A clinicopathologic study. Cancer 1993;71(5):1761–73. DOI:10.1002/1097-0142(19930301)71: 53.0.co;2-7.; Maarouf A., Scoazec J., Berger F., Partensky C. Cystic leiomyosarcoma of the pancreas successfully treated by splenopancreatectomy. A 20-year follow-up. Pancreas 2007;35:95–7. DOI:10.1097/01.mpa.0000278689.86306.70.; DeAlva E., Tarramade J., Vazquez J., Leiomyosarcoma of the pancreas. Virchows Arch 1993;422:419–22. DOI:10.1007/BF01605462.; Lakhoo K., Maunell A. Pancreatic leiomyosarcoma: a case report. S Afr J Surg 1991;29(2):59–60.; Hollenbeck S.T., Grobmyer S.R., Kent K.C., Brennan M.F. Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg 2003;197:575–9. DOI:10.1016/S1072-7515(03)00433-2.; Makimoto S., Hatano K., Kataoka N. et al. A case report of primary pancreatic leiomyosarcoma requiring six additional resections for recurrences. Int J Surg Case Rep 2017;41:272–6. DOI:10.1016/j.ijscr.2017.10.039.; Group ESESNW. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25(Suppl 3):iii102–12.; Hines O.J., Nelson S., QuinonesBaldrich W.J., Eilber F.R. Leiomyosarcoma of the inferior vena cava: Prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer 1999;l85:1077–83.; Casali P., Abecassis N., Bauer S. et al. Soft tissue and visceral sarcomas: ESMO– EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29. DOI:10.1093/annonc/mdy321.

  5. 5
    Academic Journal

    Συγγραφείς: Shevchuk, I. M., Pylypchuk, V. I.

    Πηγή: Hospital Surgery. Journal named by L.Ya. Kovalchuk; No. 4 (2017); 72-77 ; Госпитальная хирургия. Журнал имени Л.А. Ковальчука; № 4 (2017); 72-77 ; Шпитальна хірургія. Журнал імені Л. Я. Ковальчука; № 4 (2017); 72-77 ; 2414-4533 ; 1681-2778 ; 10.11603/2414-4533.2017.4

    Περιγραφή αρχείου: application/pdf

  6. 6
    Academic Journal

    Πηγή: Siberian journal of oncology; Том 18, № 5 (2019); 113-117 ; Сибирский онкологический журнал; Том 18, № 5 (2019); 113-117 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2019-18-5

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/1197/675; Papavramidis T., Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005; 200(6): 965–972. doi:10.1016/j.jamcollsurg.2005.02.011.; Guo N., Zhou Q.B., Chen R.F., Zou S.Q., Li Z.H., Lin Q., Wang J., Chen J.S. Diagnosis and surgical treatment of solid pseudopapillary neoplasm of the pancreas: analysis of 24 cases. Can J Surg. 2011 Dec; 54(6): 368–74. doi:10.1503/cjs.011810.; Frantz V.K. Tumors of the pancreas. Atlas of Tumor Pathology, VII. Fascicles 27 and 28. Armed Forced Institute of Pathology, Washington, DC, 1959. 32–33.; Nishihara K., Nagoshi M., Tsuneyoshi M., Yamaguchi K., Hayashi I. Papillary cystic tumors of the pancreas: assessment of their malignant potential. Cancer. 1993; 71(1): 82–92.; Zinner M.J., Shurbaji M.S., Cameron J.L. Solid and papillary epithelial neoplasms of the pancreas. Surgery. 1990 Sep; 108(3): 475–80.; Klöppel G., Luttges J., Klimstra D.S., Hamilton S.R. Pathology and genetics of tumours of the digestive system. Lyon: IARC press, 2000. 48.; Sperti C., Berselli M., Pasquali C., Pastorelli D., Pedrazzoli S. Aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature. World J Gastroenterol. 2008 Feb 14; 14(6): 960–5. doi:10.3748/wjg.14.960.; Machado M.C., Machado M.A., Bacchella T., Jukemura J., Almeida J.L., Cunha J.E. Solid pseudopapillary neoplasm of the pancreas: distinct patterns of onset, diagnosis, and prognosis for male versus female patients. Surgery. 2008 Jan; 143(1): 29–34. doi:10.1016/j.surg.2007.07.030.; Matos J.M., Grützmann R., Agaram N.P., Saeger H.D., Kumar H.R., Lillemoe K.D., Schmidt C.M. Solid pseudopapillary neoplasms of the pancreas: a multi-institutional study of 21 patients. J Surg Res. 2009 Nov; 157(1): e137–42. doi:10.1016/j.jss.2009.03.091.; Baek J.H., Lee J.M., Kim S.H., Kim S.J., Kim S.H., Lee J.Y., Han J.K., Choi B.I. Small (≤3 cm) solid pseudopapillary tumors of the pancreas at multiphasic multidetector CT. Radiology. 2010 Oct; 257(1): 97–106. doi:10.1148/radiol.10092089.; Ansari N.A., Ramalho M., Semelka R.C., Buonocore V., Gigli S., Maccioni F. Role of magnetic resonance imaging in the detection and characterization of solid pancreatic nodules: An update. World J Radiol. 2015 Nov 28; 7(11): 361–74. doi:10.4329/wjr.v7.i11.361.; Kim M.J., Jang S.J., Yu E. Loss of E-cadherin and cytoplasmicnuclear expression of β-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol. 2008 Feb; 39(2): 251–8. doi:10.1016/j.humpath.2007.06.014.; Huang H.L., Shih S.C., Chang W.H., Wang T.E., Chen M.J., Chan Y.J. Solid-pseudopapillary tumor of the pancreas: clinical experience and literature review. World J Gastroenterol. 2005 Mar 7; 11(9): 1403–9. doi:10.3748/wjg.v11.i9.1403.; Kim M.J., Choi D.W., Choi S.H., Heo J.S., Sung J.Y. Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy. Br J Surg. 2014 Sep; 101(10): 1266–71. doi:10.1002/bjs.9577.; https://www.siboncoj.ru/jour/article/view/1197

  7. 7
  8. 8
    Academic Journal

    Πηγή: Siberian journal of oncology; Том 15, № 6 (2016); 55-60 ; Сибирский онкологический журнал; Том 15, № 6 (2016); 55-60 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2016-15-6

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/447/395; BoldR.J., Chamsangavej С., ClearyK.R., JenningsM., MadrayA., Leach S.D., Abbruzzese J.L., Pisters P. W., Lee J.E., Evans D.B. Major vascular resection as part of pancreatoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointestinal Surg. 1999; 3 (3): 233-243.; Cao Z., Xu J., Shao Q., Zhang T., Zhao Y. Surgical treatment of pancreatic head cancer: concept revolutions and arguments. Chin J Cancer Res. 2015 Aug; 27 (4): 392-6. doi:10.3978/j.issn.1000-9604 .2015.04.13.; HiranoS., KondoS., Hara T., Ambo Y., TanakaE., Shichinohe T., Suzuki O., HazamaK. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007 Jul; 246 (1): 46-51. doi:10.1097/01.sla.0000258608.52615.5a.; Elberm H., Ravikumar R., Sabin C., Abu Hilal M., Al-Hilli A., Aroori S., Bond-Smith G., Bramhall S., Coldham C., Hammond J., Hutchins R., Imber C., Preziosi G., Saleh A., Silva M., Simpson J., Spoletini G., Stell D., Terrace J., White S., Wigmore S., Fusai G. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK vascular Resection for Pancreatic Cancer Study Group. Eur J Surg Oncol. 2015 Nov; 41 (11): 1500-7. doi:10.1016/j.ejso.2015.08.158.; Wang W.L., Ye S., Yan S., Shen Y., Zhang M., Wu J., Zheng S.S. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients withpancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int. 2015 Aug; 14 (4): 429-35.; Chen Y.T., JiangQ.L., Zhu Z., WangS., ZhaoX.M., LanZ.M., CheX., Zhang J.W., CuiL., TangX.L., Wang C.F. Resection ofthe main trunk of the superior mesenteric vein without reconstruction during surgery for giant pancreatic mucinous cystadenoma: A case report World J Gastroenterol. 2015 Jun 28; 21 (24): 7604-7. doi:10.3748/wjg.v21.i24.7604.; Shimada K., Sakamoto Y., Sano Т., Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery 2006; 139 (3): 288-95.; Sunada S., MiyataМ., Tanaka Y., OkumuraK., NakamuroM., Kita-gawa T., Shirakura R., Kawashima Y. Aggressive resection for advanced pancreatic carcinoma. Surg Today. 1992; 22 (1): 74-77.; KonishiM., Kinoshita T., Nakagori T., InoueK., Oda T., Kimata T., Kikuchi H., Ryu M. Distal pancreatectomy with resection ofthe celiac axisf the pancreas. J Hepatobiliary Pancreat Surg. 2000; 7 (2): 183-7.; Koehler R.E., Korobkin М., Lewis F. Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology. 1975; 117 (1): 49-54.; Alizai P.H., Mahnken A.H., Klink C.D., Neumann U.P., Junge K. Extended distal pancreatectomy with en bloc resection of the celiac axis for locally advanced pancreatic cancer: a case report and review of the literature. Case Rep Med. 2012; 2012: 543167. doi:10.1155/2012/543167.; Kondo S., Katoh H., Hirano S., Ambo Y., Ambo Y., Tanaka E., Okushiba S., Morikawa T. Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body. Langenbecks Arch Surg. 2003; 388 (2): 101-6.; Kondo S., Katoh H., Omi М., Hirano S., Ambo Y., Tanaka E., Okushiba S., Morikawa T., Kanai M., Yano T. Radical distal pancreatec-tomy with en bloc resection of the celiac artery, plexus, and ganglions for advanced cancer of the pancreatic body: a preliminary report on perfect pain relief. JOP. 2002; 2 (3): 93-97.; Yamagami T., YoshimatsuR., KajiwaraK., IshikawaM., Murakami Y., Uemura K., Awai K. Arteriography after embolization before distal pancre-atectomy with en bloc celiac axis resection. Minim Invasive Ther Allied Technol. 2015; 24 (6): 350-5. doi:10.3109/13645706.2015.1034729; Abo D., Hasegawa Y., Sakuhara Y., Terae S., Shimizu T., Tha K.K., TanakaE., Hirano S., Kondo S., ShiratoH. Feasibility of a dual microcathe-ter-dual interlocking detachable coil technique in preoperative embolization in preparation for distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer. J Hepatobiliary Pancreat Sci. 2012 Jul; 19 (4): 431-7. doi:10.1007/s00534-011-0455-9.; Denecke T., Andreou A., Podrabsky P., Grieser C., Warnick P., Bahra M., Klein F., Hamm B., Neuhaus P., Glanemann M. Distal pancre-atectomy with en bloc resection of the celiac trunk for extended pancreatic tumor disease: an interdisciplinary approach. Cardiovasc Intervent Radiol. 2011 Oct; 34 (5): 1058-64.; Tanaka E., Hirano S., Tsuchikawa T., Kato K., Matsumoto J., Shichinohe T. Important technical remarks on distal pancreatectomy with en-bloc celiac axis resection for locally advanced pancreatic body cancer. J Hepatobiliary Pancreat Sci. 2012 Mar; 19 (2): 141-7. doi:10.1007/s00534-011-0473-7.; https://www.siboncoj.ru/jour/article/view/447

  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20